Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control

γδT cell receptors (γδTCRs) recognize a broad range of malignantly transformed cells in mainly a major histocompatibility complex (MHC)-independent manner, making them valuable additions to the engineered immune effector cell therapy that currently focuses primarily on αβTCRs and chimeric antigen re...

Descripción completa

Detalles Bibliográficos
Autores principales: Johanna, Inez, Hernández-López, Patricia, Heijhuurs, Sabine, Scheper, Wouter, Bongiovanni, Laura, de Bruin, Alain, Beringer, Dennis X., Oostvogels, Rimke, Straetemans, Trudy, Sebestyen, Zsolt, Kuball, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573335/
https://www.ncbi.nlm.nih.gov/pubmed/34759930
http://dx.doi.org/10.3389/fimmu.2021.752699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573335/
https://www.ncbi.nlm.nih.gov/pubmed/34759930
http://dx.doi.org/10.3389/fimmu.2021.752699

Ejemplares similares